Demonstration of systemic antitumor immunity via intratumoral regulated expression of IL-12 as a gene therapy approach to treatment of cancer

被引：0
|
作者：
Barrett, John A. [1 ]
Chan, Tim [2 ]
Cai, Hongliang [1 ]
Miao, John [1 ]
Krishnan, Suma [2 ]
Lebel, Francois [1 ]
机构：
[1] Ziopharm Oncol, Boston, MA USA
[2] Intrexon, Germantown, MD USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-B091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B091
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Demonstration of systemic antitumor immunity via intratumoral regulated expression of IL-12 in advanced breast cancer and melanoma patients
    Lebel, Francois
    Barrett, John A.
    Cai, Hongliang
    Miao, John
    Krishnan, Suma
    Cooper, Laurence J. N.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [2] Intratumoral Regulated Expression of IL-12 as a Gene Therapy Approach To Immunotherapy
    Nemuanitis, John
    Barrett, John A.
    Lebel, Francois
    Reed, Thomas D.
    Chiocca, E. Antonio
    Omuro, Antonio M.
    Norton, Larry
    Lewis, Jonathan
    MOLECULAR THERAPY, 2014, 22 : S103 - S103
  • [3] Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma
    John J Nemunaitis
    Gerald P Linette
    Omid Hamid
    Sanjiv S Agarwala
    Alexander Starodub
    Lei Sun
    Francois Lebel
    John A Barrett
    Jonathan Lewis
    Journal of Translational Medicine, 12 (Suppl 1)
  • [4] Intratumoral IL-12 and TNF-α-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity
    Sabel, MS
    Skitzki, J
    Stoolman, L
    Egilmez, NK
    Mathiowitz, E
    Bailey, N
    Chang, WJ
    Chang, AE
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : 147 - 156
  • [5] Intratumoral IL-12 and TNF-α–Loaded Microspheres Lead To Regression of Breast Cancer and Systemic Antitumor Immunity
    Michael S. Sabel
    Joseph Skitzki
    Lloyd Stoolman
    Nejat K. Egilmez
    Edith Mathiowitz
    Nicola Bailey
    Wen-Jian Chang
    Alfred E. Chang
    Annals of Surgical Oncology, 2004, 11 : 147 - 156
  • [6] Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
    John A. Barrett
    Hongliang Cai
    John Miao
    Pranay D. Khare
    Paul Gonzalez
    Jessica Dalsing-Hernandez
    Geeta Sharma
    Tim Chan
    Laurence J.N Cooper
    Francois Lebel
    Cancer Gene Therapy, 2018, 25 : 106 - 116
  • [7] Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
    Barrett, John A.
    Cai, Hongliang
    Miao, John
    Khare, Pranay D.
    Gonzalez, Paul
    Dalsing-Hernandez, Jessica
    Sharma, Geeta
    Chan, Tim
    Cooper, Laurence J. N.
    Lebel, Francois
    CANCER GENE THERAPY, 2018, 25 (5-6) : 106 - 116
  • [8] Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma
    Pavlin, Darja
    Cemazar, Maja
    Kamensek, Urska
    Tozon, Natasa
    Pogacnik, Azra
    Sersa, Gregor
    CANCER BIOLOGY & THERAPY, 2009, 8 (22) : 2114 - 2122
  • [9] Regulated intratumoral expression of IL-12 in combination with cytotoxic agents as a strategy for the treatment of metastatic breast cancer
    Nemunaitis, J.
    McArthur, H.
    Hudis, C.
    Reed, T.
    Broder, S.
    Lebel, F.
    Barrett, J.
    Lewis, J.
    Norton, L.
    CANCER RESEARCH, 2013, 73
  • [10] Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: A direct comparison with systemic IL-12 protein therapy
    Rakhmilevich, AL
    Timmins, JG
    Janssen, K
    Pohlmann, EL
    Sheehy, MJ
    Yang, NS
    JOURNAL OF IMMUNOTHERAPY, 1999, 22 (02): : 135 - 144
12345